Publications found:
86
Sort by:
GLP-1 Agonists Market by Product (Ozempic, Wegovy, Mounjaro), Molecule (semaglutide, tirzepatide), Type (Patented, Biosimilars), Format (Single dose, Multi-dose, Tablets), ROA (SC, Oral), Indication (Diabetes, Obesity) - Global Forecast to 2033
US$ 4,950.00
The GLP-1 agonists market is expected to reach USD 170.75 billion in 2033 from USD 64.42 billion in 2025 at a CAGR of 13.0% during the forecast period. The GLP-1 agonists market has expanded rapidly d...
October 2025
456 pages
Glucagon-Like Peptide 1 Market Outlook 2025-2034: Market Share, and Growth Analysis By Product (Trulicity, Ozempic, Victoza, Rybelsus, Other Types), By Route of Administration (Oral, Parenteral, Other Routes), By End-Users
US$ 3,950.00
The Glucagon-Like Peptide 1 Market is valued at USD 18.1 billion in 2025 and is projected to grow at a CAGR of 8.1% to reach USD 36.5 billion by 2034. Glucagon-like Peptide 1 Market Overview The Gluca...
October 2025
160 pages
Insulin Drugs Market Outlook 2025-2034: Market Share, and Growth Analysis By Product Type (Basal Or Long-Acting Insulins, Bolus Or Fast-Acting Insulins, Pre-Mixed, And Intermediate And Short Acting Insulins), By Source Type (Insulin Analogs, And Human Insulin), By Drug Classification, By Application, By Distribution Channel
US$ 3,950.00
The Insulin Drugs Market is valued at USD 33.1 billion in 2025 and is projected to grow at a CAGR of 12.8% to reach USD 97.6 billion by 2034.The global insulin drugs market has become a cornerstone of...
October 2025
160 pages
Global Voglibose Market Growth 2025-2031
US$ 3,660.00
The global Voglibose market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest U.S. tariff meas...
October 2025
123 pages
Global Type 1 Diabetes (T1D) Market Growth 2025-2031
US$ 3,660.00
The global Type 1 Diabetes (T1D) market size is predicted to grow from US$ 2175 million in 2025 to US$ 2877 million in 2031; it is expected to grow at a CAGR of 4.8% from 2025 to 2031. The impact of t...
October 2025
125 pages
Global Type 2 Diabetes Market Growth 2025-2031
US$ 3,660.00
The global Type 2 Diabetes market size is predicted to grow from US$ 81440 million in 2025 to US$ 137170 million in 2031; it is expected to grow at a CAGR of 9.1% from 2025 to 2031. The impact of the...
October 2025
99 pages
Global Antidiabetic Drug Market Growth 2025-2031
US$ 3,660.00
The global Antidiabetic Drug market size is predicted to grow from US$ 57660 million in 2025 to US$ 104250 million in 2031; it is expected to grow at a CAGR of 10.4% from 2025 to 2031. The impact of t...
October 2025
114 pages
Global Insulin Detemir Market Growth 2025-2031
US$ 3,660.00
The global Insulin Detemir market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest U.S. tarif...
October 2025
75 pages
Global Human Insulin Market Growth 2025-2031
US$ 3,660.00
The global Human Insulin market size is predicted to grow from US$ 71010 million in 2025 to US$ 123820 million in 2031; it is expected to grow at a CAGR of 9.7% from 2025 to 2031. The impact of the la...
October 2025
91 pages
Global Antidiabetic Biguanides Market Growth 2025-2031
US$ 3,660.00
The global Antidiabetic Biguanides market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest U....
October 2025
123 pages
Global Antidiabetic SGLT-2 Inhibitor Market Growth 2025-2031
US$ 3,660.00
The global Antidiabetic SGLT-2 Inhibitor market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the lat...
October 2025
106 pages
Global Antidiabetic Sulphonylureas Market Growth 2025-2031
US$ 3,660.00
The global Antidiabetic Sulphonylureas market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the lates...
October 2025
106 pages
Global Diabetes Therapeutics Market - 2025 -2033
US$ 4,350.00
Global Diabetes Therapeutics Market: Industry Outlook The global diabetes therapeutics market reached US$ 76.75 Billion in 2023, with a rise of US$ 89.46 Billion in 2024 and is expected to reach US$ 3...
October 2025
180 pages
Global Insulin Resistance Market - 2025 -2033
US$ 4,350.00
Insulin Resistance Market Size & Industry Outlook The global insulin resistance market size reached US$ 36.54 Billion in 2024 from US$ 35.12 Billion in 2023 and is expected to reach US$ 53.71 Billion...
October 2025
180 pages
Global GLP-1 Agonist Market Growth 2025-2031
US$ 3,660.00
The global GLP-1 Agonist market size is predicted to grow from US$ 23000 million in 2025 to US$ 59680 million in 2031; it is expected to grow at a CAGR of 17.2% from 2025 to 2031. GLP-1 is a polypepti...
September 2025
102 pages
Global GLP-1RA Drugs Market Growth 2025-2031
US$ 3,660.00
The global GLP-1RA Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. United States market for GLP-1RA Drug...
September 2025
101 pages
Diabetic Foot Ulcer Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment (Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications, and Others), By Ulcer Type (Neuropathic Ulcers, Ischemic Ulcers, and Neuroischemic Ulcers), By End User (Hospitals & Clinics, Ambulatory Care Centers, and Others), By Region and Competition, 2020-2030F
US$ 4,500.00
Market Overview Global Diabetic Foot Ulcer Treatment Market was valued at USD 5.51 billion in 2024 and is expected to reach USD 8.48 billion by 2030 with a CAGR of 7.45% during the forecast period. T...
August 2025
180 pages
Diabetic Ketoacidosis Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment Type (Fluid Replacement Therapy, Electrolyte Replacement Therapy, Insulin Therapy, Others), By End User (Hospitals, Ambulatory Surgical Centers (ASCs), Homecare Settings), By Region and Competition, 2020-2030F
US$ 4,500.00
Market Overview The Global Diabetic Ketoacidosis Treatment Market was valued at USD 4.08 Billion in 2024 and is expected to reach USD 5.70 Billion by 2030 with a CAGR of 5.71%. The Global Diabetic Ke...
August 2025
183 pages
SGLT2 Inhibitors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug (Jardiance, Farmiga, Inpefa, Invokana, Others), By Indication (Type 2 Diabetes, Cardiovascular, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
Market Overview Global SGLT2 Inhibitors Market was valued at USD 15.37 Billion in 2024 and is expected to reach USD 21.44 Billion by 2030 with a CAGR of 5.90%. These oral antidiabetic agents have eme...
August 2025
185 pages
SGLT2 Inhibitors Market Size, Share & Trends Analysis Report By Drug (Jardiance, Farxiga, Inpefa, Invokana), By Indication (Type 2 Diabetes, Cardiovascular), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
SGLT2 Inhibitors Market The global SGLT2 inhibitors market size was estimated at USD 16.8 billion in 2024 and is projected to reach USD 28.9 billion by 2033, growing at a CAGR of 6.19% from 2025 to 20...
August 2025
150 pages
Diabetic Food Market Report by Product Type (Bakery Products, Dairy Products, Confectionery Products, Beverages, Snacks, Spreads, and Others), End Consumers (Children, Adults), Distribution Channel (Supermarkets and Hypermarkets, Drug Stores/Pharmacies, Grocery Stores, Online Stores, and Others), and Region 2025-2033
US$ 3,999.00
The global diabetic food market size reached USD 12.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 23.3 billion by 2033, exhibiting a growth rate (CAGR) of 6.47% durin...
August 2025
138 pages
Diabetic Food Market Size, Share, and Analysis By Product Type (Confectionery, Bakery Product, Dairy Product, Dietary Beverages, and Others), By Distribution Channel (Super Market, Hyper Market, and Grocery Stores, and Others), and By Region (North America, Europe, Asia-Pacific, And Rest of the World) And Regional Forecast 2023-2032
US$ 5,150.00
Diabetic Food Market Size, Share, and Analysis By Product Type (Confectionery, Bakery Product, Dairy Product, Dietary Beverages, and Others), By Distribution Channel (Super Market, Hyper Market, and G...
January 2024
461 pages
Global Diabetes Drug Market & Pipeline Insight 2015
US$ 2,400.00
... Global Diabetes Drug Market Overview Global Diabetic Drug Clinical Pipeline by Company & Phase Global Diabetic Drug Clinical Pipeline: 817 Drugs Majority in Preclinical Phase: 205 Drugs Type 2 Diabetes Mellitus Drugs in Pipeline: 380 Drugs Type 1 Diabetes Mellitus Drugs in Pipeline: 79 Drugs Diabetic ...
April 2015
1100 pages
